ESCRS - PP16.02 - Safety And Efficacy Outcomes With A New Continuous-Range-Of-Vision Intraocular Lens

Safety And Efficacy Outcomes With A New Continuous-Range-Of-Vision Intraocular Lens

Published 2022 - 40th Congress of the ESCRS

Reference: PP16.02 | Type: Free paper | DOI: 10.82333/d5s2-sg22

Authors: David Teenan* 1 , Stephen Hannan 1 , Jan Venter 1

1Clinical Services,Optical Express,Glasgow,United Kingdom

Purpose

To report on the safety and efficacy outcomes a new TECNIS Synergy ZFR00V premium IOL indicated for patients looking for an improved continuous-range-of-vision.

Setting

Private Refractive Surgery (Optical Express)

Methods

Outcomes of 324 presbyopic patients who underwent cataract surgery or refractive lens exchange with bilateral implantation of the TECNIS Synergy ZFR00V are reported. The age range of patients was 37 to 79 years, with pre-op refractive range of +7.25D to -11.25D and up to -3.50D of refractive astigmatism. Post-implant clinical safety and efficacy outcomes in addition to patient reported outcomes were analysed. 

Results

Mean postoperative binocular distance visual acuity was +0.03 logMAR (range -0.18 to +0.52); intermediate visual acuity was -0.05 logMAR (range -0.30 to +0.32); and near visual acuity was +0.13 logMAR (range -0.10 to +0.50). The mean gain of lines for distance visual acuity was 5, lines gained of intermediate was 6 and 7 lines of near visual acuity. Thirteen of the 549 implanted eyes recorded >2 lines loss of BCDVA, 2.4%. Procedure recommendation rates are high. Adverse event rates with this premium IOL remain low.

Conclusions

The safety and efficacy outcomes for this new continuous-range-of-vision IOL suggest it may be a good alternative for patients looking for meaningful gains in uncorrected visual acuities at distant, intermediate, and near ranges. Longer follow-up is warranted to better understand the comparative performance of this IOL.